The U.S. government received hundreds of millions of dollars from vaccine manufacturer Moderna, according to a newly disclosed contract.
Moderna agreed to pay the U.S. National Institutes of Health (NIH) to license spike protein technology that the company used in its COVID-19 vaccine, according to the contract.